Polyvalent bacteria capsule polysaccharide-protein conjugate combined vaccine

Polyvalent bacteria capsule polysaccharide-protein conjugate combined vaccine

  • CN 1,709,505 A
  • Filed: 07/13/2005
  • Published: 12/21/2005
  • Est. Priority Date: 07/13/2005
  • Status: Active Grant
First Claim
Patent Images

1. , a kind of polyvalent bacterial polysaccharide-protein conjugate combined vaccine preparation, it is characterized in that, the A group'"'"'s epidemic cerebrospinal meningitis Neisseria gonorrhoeae capsular polysaccharide-protein conjugates that contains effective dose, C group'"'"'s epidemic cerebrospinal meningitis Neisseria gonorrhoeae pod membrane capsular polysaccharide-protein conjugates, Y group'"'"'s epidemic cerebrospinal meningitis Neisseria gonorrhoeae capsular polysaccharide-protein conjugates, W135 group'"'"'s epidemic cerebrospinal meningitis Neisseria gonorrhoeae capsular polysaccharide-protein conjugates and b type hemophilus influenza capsular polysaccharide-protein conjugates, the part by weight between them is between 1:

  • 0.5~

    2.5.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×